Manufacturer record
Brussels Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Brussels Laboratories Pvt. Ltd (Gujarat) were declared Not of Standard Quality between July 2023 and January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ZA23019, Paracetamol Oral Suspension BP (100 ml) 120 mg/ 5 ml (exp Jun 2026). CDTL Mumbai (CDSCO lab) found it not of standard quality: Assay of Paracetamol. Listed in the January 2025 alert.
Records by type
2 records linked to Brussels Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Oral Suspension BP (100 ml) 120 mg/ 5 ml | Batch ZA23019Mfg Jul 2023 · Exp Jun 2026 | Assay of ParacetamolAssay | CDTL MumbaiCDSCO lab | Jan 2025 |
| Diclofenac Sodium, Paracetamol and Serratiopeptidase Tablets | Batch F23018Mfg Feb 2023 · Exp Jan 2026 | Assay of SerratiopeptidaseAssay | CDL KolkataCDSCO lab | Jul 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.